Skip to main content
April 02, 2020
Among the countless impacts of the COVID-19 crisis on addiction treatment operations, providers suddenly have had to rethink standard protocols for patient drug testing. The vice president of addiction services at Dominion Diagnostics tells Addiction Professional that an immediate effort to protect…
February 21, 2020
Besides confirming its earlier reports of substantial increases in positive drug test rates for methamphetamine and rising co-occurrence of fentanyl with several drugs, the latest data from Millennium Health suggest increasing use of the highly controversial substance kratom.
January 27, 2020
The two main conclusions of the Emerging Threats Report 2019 from the National Emerging Threats Initiative (NETI) likely will not surprise many who are involved in anti-drug efforts: The trend that fueled the opioid crisis has peaked and should remain in decline, while supply and demand associated…
January 10, 2020
The latest comprehensive analysis of urine drug test data from Millennium Health suggests that the “stimulant crisis” many experts are predicting might actually be playing out more narrowly as a methamphetamine crisis.
October 16, 2019
Physicians are finding themselves caught in two dilemmas affecting them at the same time: the need to better understand treatment options for patients with opioid use disorders, and the issue of how to assist pain patients who suddenly feel shunned by the medical community.
May 06, 2019
A Millennium Health analysis adds to the evidence that fentanyl now has a dangerously prominent presence in the cocaine and methamphetamine supply.
April 08, 2019
An Australian study has found that a substantial number of young victims of a fatal stroke were stimulant users.
March 29, 2019
A study being conducted at outpatient clinics in the Northeast and Northwest will evaluate whether buprenorphine patients' medication adherence will improve via regular filming of their administering the drug.
March 14, 2019
A trends report from Millennium Health indicates a frequent presence of other substances, particularly marijuana, in patients prescribed buprenorphine for opioid dependence.
March 01, 2019
Belden, Inc.'s often-cited effort to assist job applicants who fail a pre-employment drug test will be expanded to two additional company locations.
Back to Top